Your Ad Here
PatientsVille.com> Cabergoline Report List> Cabergoline Side Effects
If You had Cabergoline side effect, You are not alone. Other patients reported side effects.
Do You Have Cabergoline Side Effects? Enter Your Symptoms:
Use to quickly submit your side effect

What can I take for the head aches? Is it normal to wake ...Keep Reading

I'm suffering from Micro-prolatinoma, so that doctor suggested me Cabergoline, it's giving ...Keep Reading

Using cabergoline for almost a year now, however , am not able ...Keep Reading

extreme back pain. would seem to be associated with menstrual cycle. Like ...Keep Reading

the doctor has advised me cabergoline 0.5 mg tabs on 2 alternate days ...Keep Reading

It has actually been a giant, giant miracle drug for me, but ...Keep Reading

Also want to mention that I had a very slow heartbeat before starting this ...Keep Reading

Im not sure about what happened to me the last 2 days, but ...Keep Reading

If this was an anaphylatic shock due to taking Cabergoline, I dont why ...Keep Reading

View More

Indicate Your Cabergoline Side Effects
Hypersexual (2)
Backache (1)
Extreme Fatigue (1)
Pleural Effusion (1)
>>See All

Common Cabergoline Side Effects

top 5 Cabergoline|Hypersexua|Backache|Extreme fa|Pleural ef adverse effects>>See All Cabergoline Side Effects

Report Detailed Information

Detailed Reporting will help others get complete information and find alternative treatments to avoid or reduce side effects associated with it.

Ask Cabergoline Community

Ask patient community about Cabergoline related health issues.

View FDA Reports

Cabergoline adverse events reported to FDA.

Have You Experienced unusual Cabergoline symptoms? PatientsVille.com collects and analyzes Cabergoline side effect and adverse reports submitted by Cabergoline users, such as .

Summary

FDA Adverse Reports: 516. View All

Cabergoline FDA safety alerts: No

Reported deaths: 38

Reported hospitalizations: 235

Cabergoline Dosage, Warnings, Usage.

Post Your Unusual Symptoms:

Most Reported
1Hypersexual
2Extreme Fatigue
3Backache
4Pleural Effusion
View More
Recent Drug Reports

More Cabergoline Side Effect Reports

Questions

Ask a Doctor


13 Doctors are Online Now. Current Wait time: 7 Minutes

blog comments powered by Disqus

Often additional risks of using a medication, such as Cabergoline, become known after product is used by a larger number of patients, for a longer period of time, and by patients with different health characteristics from those studied before drug approval. This page allows You to Find answers and discuss health symptoms with other Cabergoline users, Learn more about unwanted side effects & find ways to reduce them. Browse Cabergoline Adverse Reports reported to FDA and participate in Cabergoline discussion, find alternative treatments and find ways to avoid or reduce risks associated with using Cabergoline. You can also Post a question to users community or Ask a Doctor. PatientsVille.com is Your Complete Guide to all common, undocumented and undisclosed side effects associated with drugs and vaccines. Browse More Drug Reports Here: A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Search By Drug Names, Symptoms or a Health Condition

Loading

Cabergoline Adverse Effect Reports (FDA)

For a quick way to Report Unusual Symptoms, Enter here:

Showing 1-50 of 516  Next Page  >

7021231-0 | Dopamine Dysregulation Syndrome
on Sep 15, 2010 Male patient from UNITED KINGDOM , 37 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Cabergoline (View Usage). Patient experienced the following unwanted or unexpected effects: dopamine dysregulation syndrome. Cabergoline dosage: 2 Mg, Day. During the same period patient was treated with LEVODOPA (300 Mg, Day) (View Levodopa Review and Levodopa Label ), ROTIGOTINE (4 Mg, Day) (View Rotigotine Review and Rotigotine Label ), BENZATROPINE (Unk) (View Benzatropine Review and Benzatropine Label ), TRIHEXYPHENIDYL (10 Mg, Day) (View Trihexyphenidyl Review and Trihexyphenidyl Label ).

7021230-9 | Dopamine Dysregulation Syndrome
Patient was taking Cabergoline (View Usage). Patient had the following side effects: dopamine dysregulation syndrome on Sep 15, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 66 years of age, was diagnosed with on and off phenomenon, parkinson's disease (What is parkinson's disease?) and. Cabergoline dosage: Unk. During the same period patient was treated with ENTACAPONE (Unk) (View Entacapone Review and Entacapone Label ), LEVODOPA (300 Mg, Day) (View Levodopa Review and Levodopa Label ), PERGOLIDE (3.5 Mg, Day) (View Pergolide Review and Pergolide Label ), ROPINIROLE (Unk) (View Ropinirole Review and Ropinirole Label ). Patient was hospitalized.

7021228-0 | Dopamine Dysregulation Syndrome, On And Off Phenomenon, Paranoia
Adverse event was reported on Sep 15, 2010 by a Male patient taking Cabergoline (View Usage) (Dosage: 3 Mg, Day) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: UNITED KINGDOM , 50 years of age, After Cabergoline was administered, patient had the following side effects: dopamine dysregulation syndrome, on and off phenomenon, paranoia. During the same period patient was treated with AMANTADINE (100 Mg, Day) (View Amantadine Review and Amantadine Label ), LEVODOPA (500 Mg, Day) (View Levodopa Review and Levodopa Label ), PERGOLIDE (3 Mg, Day) (View Pergolide Review and Pergolide Label ). Patient was hospitalized.

7016837-9 | Dopamine Dysregulation Syndrome
on Sep 15, 2010 Male patient from UNITED KINGDOM , 50 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Cabergoline (View Usage). Patient experienced the following unwanted or unexpected effects: dopamine dysregulation syndrome. Cabergoline dosage: 6 Mg, Daily. During the same period patient was treated with AMANTADINE (100 Mg, Daily) (View Amantadine Review and Amantadine Label ), LEVODOPA (500 Mg, Daily) (View Levodopa Review and Levodopa Label ), PERGOLIDE (3 Mg, Daily) (View Pergolide Review and Pergolide Label ). Patient was hospitalized.


7016836-7 | Dopamine Dysregulation Syndrome
on Sep 15, 2010 Male patient from UNITED KINGDOM , 37 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Cabergoline (View Usage). Patient had the following side effects: dopamine dysregulation syndrome. Cabergoline dosage: 8 Mg, Daily, Self-medicated. During the same period patient was treated with L DOPA (300 Mg, Daily) (View L-dopa Review and L-dopa Label ), ROTIGOTINE (4 Mg, Daily) (View Rotigotine Review and Rotigotine Label ), BENZTROPINE MESYLATE (4 Mg, Daily) (View Benztropine Mesylate Review and Benztropine Mesylate Label ).

7016834-3 | Dopamine Dysregulation Syndrome, Intentional Self-injury
Patient was taking Cabergoline (View Usage). After Cabergoline was administered, patient had the following side effects: dopamine dysregulation syndrome, intentional self-injury on Sep 15, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 66 years of age, was diagnosed with on and off phenomenon, parkinson's disease (What is parkinson's disease?) and. Cabergoline dosage: Up To 4 Mg/day. During the same period patient was treated with ENTACAPONE (Unk) (View Entacapone Review and Entacapone Label ), LEVODOPA (1200 Mg, Daily, Self-administered) (View Levodopa Review and Levodopa Label ), PERGOLIDE (3 1/2 Mg, Daily) (View Pergolide Review and Pergolide Label ), ROPINIROLE (Up To 32 Mg, Daily, Self-administered) (View Ropinirole Review and Ropinirole Label ). Patient was hospitalized.

7008856-3 | Blood Prolactin Increased, Cerebrospinal Fluid Rhinorrhoea
Adverse event was reported on Sep 09, 2010 by a Female patient taking Cabergoline (View Usage) (Dosage: Unk) was diagnosed with prolactinoma and. Location: UNITED KINGDOM , 55 years of age, Patient experienced the following unwanted or unexpected effects: blood prolactin increased, cerebrospinal fluid rhinorrhoea.

7008855-1 | Blood Prolactin Increased, Cerebrospinal Fluid Rhinorrhoea
on Sep 09, 2010 Male patient from UNITED KINGDOM , 39 years of age, was diagnosed with prolactinoma and was treated with Cabergoline (View Usage). Patient had the following side effects: blood prolactin increased, cerebrospinal fluid rhinorrhoea. Cabergoline dosage: Unk. During the same period patient was treated with BROMOCRIPTINE (Unk) (View Bromocriptine Review and Bromocriptine Label ).

7008854-X | Blood Prolactin Increased, Cerebrospinal Fluid Rhinorrhoea
on Sep 09, 2010 Male patient from UNITED KINGDOM , 36 years of age, was diagnosed with prolactinoma and was treated with Cabergoline (View Usage). After Cabergoline was administered, patient had the following side effects: blood prolactin increased, cerebrospinal fluid rhinorrhoea. Cabergoline dosage: Unk. During the same period patient was treated with BROMOCRIPTINE (Unk) (View Bromocriptine Review and Bromocriptine Label ).

7008853-8 | Blood Prolactin Increased, Cerebrospinal Fluid Rhinorrhoea
Patient was taking Cabergoline (View Usage). Patient experienced the following unwanted or unexpected effects: blood prolactin increased, cerebrospinal fluid rhinorrhoea on Sep 09, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 46 years of age, was diagnosed with prolactinoma and. Cabergoline dosage: Unk.

7008852-6 | Cerebrospinal Fluid Rhinorrhoea
Adverse event was reported on Sep 09, 2010 by a Male patient taking Cabergoline (View Usage) (Dosage: 0.5 Mg, Three Days A Week For 2 Months) was diagnosed with prolactinoma and. Location: ITALY , 39 years of age, Patient had the following side effects: cerebrospinal fluid rhinorrhoea. Patient was hospitalized.

7008851-4 | Cerebrospinal Fluid Rhinorrhoea
on Sep 09, 2010 Male patient from ITALY , 53 years of age, was diagnosed with prolactinoma and was treated with Cabergoline (View Usage). After Cabergoline was administered, patient had the following side effects: cerebrospinal fluid rhinorrhoea. Cabergoline dosage: 0.5 Mg, Twice A Week. Patient was hospitalized.

7008850-2 | Cerebrospinal Fluid Rhinorrhoea
on Sep 09, 2010 Male patient from ITALY , 42 years of age, was diagnosed with prolactinoma and was treated with Cabergoline (View Usage). Patient experienced the following unwanted or unexpected effects: cerebrospinal fluid rhinorrhoea. Cabergoline dosage: 0.5 Mg, 6 Days In A Week For 2 Months. Patient was hospitalized.

7006338-6 | Fatigue, Leukopenia
Patient was taking Cabergoline (View Usage). Patient had the following side effects: fatigue, leukopenia on Sep 08, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 73 years of age, weighting 173.1 lb, was diagnosed with prolactinoma and. Cabergoline dosage: 500 Mcg, 1/week. During the same period patient was treated with AMLODIPINE (View Amlodipine Review and Amlodipine Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), EZETIMIBE (View Ezetimibe Review and Ezetimibe Label ), RABEPRAZOLE SODIUM (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ).

6984552-3 | Fatigue, Leukopenia
Adverse event was reported on Sep 08, 2010 by a Male patient taking Cabergoline (View Usage) (Dosage: 500 Ug, Weekly) was diagnosed with prolactinoma and. Location: UNITED KINGDOM , 73 years of age, weighting 173.1 lb, After Cabergoline was administered, patient had the following side effects: fatigue, leukopenia. During the same period patient was treated with AMLODIPINE (Unk) (View Amlodipine Review and Amlodipine Label ), ATORVASTATIN (Unk) (View Atorvastatin Review and Atorvastatin Label ), EZETIMIBE (Unk) (View Ezetimibe Review and Ezetimibe Label ), RABEPRAZOLE (Unk) (View Rabeprazole Review and Rabeprazole Label ).

6981049-1 | Fatigue, Leukopenia
on Sep 08, 2010 Male patient from UNITED KINGDOM , 73 years of age, weighting 173.1 lb, was diagnosed with prolactinoma and was treated with Cabergoline (View Usage). Patient experienced the following unwanted or unexpected effects: fatigue, leukopenia. Cabergoline dosage: .

6980086-0 | Blood Albumin Decreased, Blood Bilirubin Decreased, Blood Chloride Increased, Blood Cortisol Decreased, Blood Creatinine Increased, Blood Gastrin Increased, Blood Glucose Decreased, Blood Sodium Decreased, Blood Urea Increased
on Aug 31, 2010 Female patient from UNITED STATES , 58 years of age, was diagnosed with prolactinoma and was treated with Cabergoline (View Usage). Patient had the following side effects: blood albumin decreased, blood bilirubin decreased, blood chloride increased, blood cortisol decreased, blood creatinine increased, blood gastrin increased, blood glucose decreased, blood sodium decreased, blood urea increased. Cabergoline dosage: 0.5 Mg, Twice A Week. During the same period patient was treated with LEVOTHYROXINE SODIUM (50 Mcg, Daily) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ). Patient was hospitalized.

6964743-8 | Cerebrospinal Fluid Rhinorrhoea, Pneumocephalus
Patient was taking Cabergoline (View Usage). After Cabergoline was administered, patient had the following side effects: cerebrospinal fluid rhinorrhoea, pneumocephalus on Aug 23, 2010 from UNITED STATES Additional patient health information: Female patient , 54 years of age, was diagnosed with multiple endocrine adenomatosis type i, prolactinoma and. Cabergoline dosage: 0.5 Mg, 2x/week. During the same period patient was treated with LEVOTHYROXINE (50 Ug, 1x/day) (View Levothyroxine Review and Levothyroxine Label ).

6882887-6 | Bronchospasm
Adverse event was reported on Jan 12, 2010 by a Female patient taking Cabergoline (View Usage) (Dosage: 0.5 Mg, Unk) was diagnosed with pituitary tumour, thyroid disorder, headache (What is headache?) and. Location: COLOMBIA , 54 years of age, Patient experienced the following unwanted or unexpected effects: bronchospasm. During the same period patient was treated with LEVOTHYROXINE (50 Mg, 1x/day) (View Levothyroxine Review and Levothyroxine Label ), ACETAMINOPHEN (50 Mg, 1x/day) (View Acetaminophen Review and Acetaminophen Label ).

6877168-0 | Priapism
on Jul 15, 2010 Male patient from SPAIN , 33 years of age, was diagnosed with prolactinoma and was treated with Cabergoline (View Usage). Patient had the following side effects: priapism. Cabergoline dosage: Unk. Patient was hospitalized.

6871308-5 | Aortic Valve Incompetence, Cardiac Valve Disease, Cerebrovascular Accident, Depression Suicidal, Divorced, Dyspnoea, Fluid Retention, Hepatic Cirrhosis, Hepatic Steatosis
on Jul 13, 2010 Male patient from GERMANY , 57 years of age, was diagnosed with restless legs syndrome and was treated with Cabergoline (View Usage). After Cabergoline was administered, patient had the following side effects: aortic valve incompetence, cardiac valve disease, cerebrovascular accident, depression suicidal, divorced, dyspnoea, fluid retention, hepatic cirrhosis, hepatic steatosis. Cabergoline dosage: 4 Mg, 1x/day. During the same period patient was treated with ASPIRIN (100 Mg, 1x/day) (View Aspirin Review and Aspirin Label ), SIMVASTATIN (20 Mg, 2x/day) (View Simvastatin Review and Simvastatin Label ), TOREM (10 Mg, 2x/day) (View Torem Review and Torem Label ), ALLOPURINOL (200 Mg, 1x/day) (View Allopurinol Review and Allopurinol Label ), PANTOZOL (40 Mg, 1x/day) (View Pantozol Review and Pantozol Label ), FERRO SANOL (20 Gtt, 1x/day) (View Ferro Sanol Review and Ferro Sanol Label ), DELIX PLUS (1 Df, 1x/day) (View Delix Plus Review and Delix Plus Label ), MADOPAR (50 Mg, 3x/day) (View Madopar Review and Madopar Label ). Patient was hospitalized.

6863804-1 | Caesarean Section, Complication Of Delivery
Patient was taking Cabergoline (View Usage). Patient experienced the following unwanted or unexpected effects: caesarean section, complication of delivery on Jul 08, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 37 years of age, weighting 136.0 lb, was diagnosed with hyperprolactinaemia and. Cabergoline dosage: Unk. Patient was hospitalized.

6847485-9 | Cardiac Valve Disease, Depression, Dyspnoea, Fluid Retention, Impulse-control Disorder, Pathological Gambling, Suicide Attempt
Adverse event was reported on Jul 07, 2010 by a Male patient taking Cabergoline (View Usage) (Dosage: 2 Mg, 1x/day) was diagnosed with restless legs syndrome and. Location: GERMANY , 57 years of age, Patient had the following side effects: cardiac valve disease, depression (What is depression?), dyspnoea, fluid retention, impulse-control disorder, pathological gambling, suicide attempt. During the same period patient was treated with CHOLESTEROL (View Cholesterol Review and Cholesterol Label ).

6839144-3 | Caesarean Section
on Jul 09, 2010 Female patient from UNITED KINGDOM , 37 years of age, weighting 136.0 lb, was diagnosed with hyperprolactinaemia and was treated with Cabergoline (View Usage). After Cabergoline was administered, patient had the following side effects: caesarean section. Cabergoline dosage: .

6817796-1 | Caesarean Section
on Jun 23, 2010 Female patient from UNITED KINGDOM , 37 years of age, weighting 136.0 lb, was diagnosed with hyperprolactinaemia and was treated with Cabergoline (View Usage). Patient experienced the following unwanted or unexpected effects: caesarean section. Cabergoline dosage: Unk.

6804119-7 | Blood Prolactin Increased, Fatigue, Insomnia, Mood Altered, Weight Decreased
Patient was taking Cabergoline (View Usage). Patient had the following side effects: blood prolactin increased, fatigue, insomnia, mood altered, weight decreased on Mar 02, 2007 from UNITED STATES Additional patient health information: Female patient , weighting 165.0 lb, was diagnosed with pituitary tumour benign and. Cabergoline dosage: 2 Every 1 Weeks. During the same period patient was treated with DOSTINEX (2 Every 1 Weeks) (View Dostinex Review and Dostinex Label ).

6804095-7 | Headache, Insomnia, Malaise, Nausea, Psychomotor Hyperactivity
Adverse event was reported on Dec 26, 2006 by a Female patient taking Cabergoline (View Usage) (Dosage: 2 Every 1 Weeks) was diagnosed with pituitary tumour benign, hyperprolactinaemia, thyroid disorder and. Location: UNITED STATES , weighting 159.0 lb, After Cabergoline was administered, patient had the following side effects: headache (What is headache?), insomnia, malaise, nausea (What is nausea?), psychomotor hyperactivity. During the same period patient was treated with DOSTINEX (2 Every 1 Weeks) (View Dostinex Review and Dostinex Label ), LEVOXYL (View Levoxyl Review and Levoxyl Label ).

6775382-6 | Neoplasm Progression
on Jun 08, 2010 Male patient from ARGENTINA , 70 years of age, was diagnosed with prolactinoma and was treated with Cabergoline (View Usage). Patient experienced the following unwanted or unexpected effects: neoplasm progression. Cabergoline dosage: 1 Mg, Weekly.

6738726-7 | Cerebrospinal Fluid Rhinorrhoea
on May 13, 2010 Male patient from JAPAN , 40 years of age, was diagnosed with prolactin-producing pituitary tumour and was treated with Cabergoline (View Usage). Patient had the following side effects: cerebrospinal fluid rhinorrhoea. Cabergoline dosage: 0.25 Mg, Weekly.

6733017-2 | Abnormal Behaviour, Aortic Valve Calcification, Blood Albumin Decreased, Blood Glucose Increased, Disorientation, Dyspnoea, Gait Disturbance, Lung Disorder
Patient was taking Cabergoline (View Usage). After Cabergoline was administered, patient had the following side effects: abnormal behaviour, aortic valve calcification, blood albumin decreased, blood glucose increased, disorientation, dyspnoea, gait disturbance, lung disorder on Apr 30, 2010 from JAPAN Additional patient health information: Male patient , 80 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Cabergoline dosage: 3 Mg Daily. Patient was hospitalized.

6731753-5 | Retroperitoneal Fibrosis
Adverse event was reported on May 10, 2010 by a Female patient taking Cabergoline (View Usage) (Dosage: 0.5 To 1.0 Mg Per Day) was diagnosed with hypophysitis, hyperprolactinaemia, galactorrhoea and. Location: JAPAN , 45 years of age, Patient experienced the following unwanted or unexpected effects: retroperitoneal fibrosis.

6712022-6 | Oestradiol Increased
on Apr 23, 2010 Female patient from JAPAN , 47 years of age, was treated with Cabergoline (View Usage). Patient had the following side effects: oestradiol increased. Cabergoline dosage: .

6707942-2 | Dystonia, Gastrointestinal Disorder, Incorrect Dose Administered, Torticollis
on Apr 13, 2010 Male patient from JAPAN , 80 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Cabergoline (View Usage). After Cabergoline was administered, patient had the following side effects: dystonia (What is dystonia?), gastrointestinal disorder, incorrect dose administered, torticollis. Cabergoline dosage: 1 Mg, Tid; 0.25 Mg, Tid. During the same period patient was treated with LEVODOPA BENSERAZIDE HYDROCHLO (BENSERAZIDE HYDROCHLORIDE, LEVODOPA) (View Levodopa Benserazide Hydrochlo (benserazide Hydrochloride, Levodopa) Review and Levodopa Benserazide Hydrochlo (benserazide Hydrochloride, Levodopa) Label ).

6707588-6 | Akinesia, Posture Abnormal, Torticollis
Patient was taking Cabergoline (View Usage). Patient experienced the following unwanted or unexpected effects: akinesia, posture abnormal, torticollis on Apr 13, 2010 from JAPAN Additional patient health information: Male patient , 69 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Cabergoline dosage: .

6704142-7 | Cerebrospinal Fluid Rhinorrhoea
Adverse event was reported on Apr 21, 2010 by a Male patient taking Cabergoline (View Usage) (Dosage: 0.25 Mg, Weekly) was diagnosed with prolactin-producing pituitary tumour and. Location: JAPAN , 40 years of age, Patient had the following side effects: cerebrospinal fluid rhinorrhoea.

6703988-9 | Disease Progression, Lung Disorder, Pleural Effusion
on Apr 17, 2010 Male patient from UNITED KINGDOM , 57 years of age, was treated with Cabergoline (View Usage). After Cabergoline was administered, patient had the following side effects: disease progression, lung disorder, pleural effusion. Cabergoline dosage: Unk. During the same period patient was treated with BROMOCRIPTINE (30 Mg, Daily) (View Bromocriptine Review and Bromocriptine Label ).

6703987-7 | Interstitial Lung Disease
on Apr 17, 2010 Male patient from UNITED KINGDOM , 65 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Cabergoline (View Usage). Patient experienced the following unwanted or unexpected effects: interstitial lung disease. Cabergoline dosage: 1 Mg, Daily. Patient was hospitalized.

6699082-6 | Atelectasis, Dyspnoea, Pleural Effusion, Pleuritic Pain, Pulmonary Fibrosis
Patient was taking Cabergoline (View Usage). Patient had the following side effects: atelectasis, dyspnoea, pleural effusion, pleuritic pain, pulmonary fibrosis (What is pulmonary fibrosis?) on Apr 16, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 62 years of age, . Cabergoline dosage: 10 Mg, Daily. Patient was hospitalized.

6693284-0 | Antiphospholipid Antibodies Positive, Arthralgia, Dyspnoea, Mixed Connective Tissue Disease, Pulmonary Hypertension, Raynaud's Phenomenon
Adverse event was reported on Apr 21, 2010 by a Female patient taking Cabergoline (View Usage) (Dosage: 0.5 Mg Twice A Week Po) was diagnosed with prolactinoma and. Location: UNITED STATES , weighting 143.0 lb, After Cabergoline was administered, patient had the following side effects: antiphospholipid antibodies positive, arthralgia, dyspnoea, mixed connective tissue disease, pulmonary hypertension (What is pulmonary hypertension?), raynaud's phenomenon.

6689975-8 | Hip Arthroplasty
on Jan 25, 2010 Male patient from GERMANY , 70 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Cabergoline (View Usage). Patient experienced the following unwanted or unexpected effects: hip arthroplasty. Cabergoline dosage: 1 Mg, 1x/day. Patient was hospitalized.

6681878-8 | Torticollis
on Mar 26, 2010 Male patient from JAPAN , 80 years of age, was treated with Cabergoline (View Usage). Patient had the following side effects: torticollis. Cabergoline dosage: 3 Mg. During the same period patient was treated with CARBIDOPA + LEVODOPA (View Carbidopa + Levodopa Review and Carbidopa + Levodopa Label ).

6681869-7 | Torticollis
Patient was taking Cabergoline (View Usage). After Cabergoline was administered, patient had the following side effects: torticollis on Mar 26, 2010 from JAPAN Additional patient health information: Male patient , 69 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Cabergoline dosage: .

6681671-6 | Condition Aggravated, Parkinson's Disease, Torticollis
Adverse event was reported on Mar 26, 2010 by a Female patient taking Cabergoline (View Usage) (Dosage: 3 Mg, Qd) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: JAPAN , 47 years of age, Patient experienced the following unwanted or unexpected effects: condition aggravated, parkinson's disease (What is parkinson's disease?), torticollis. During the same period patient was treated with PRAMIPEXOL DIHYDROCHLORIDE (MIRAPEX) (2 Mg, Qd ; 1 Mg, Qd) (View Pramipexol Dihydrochloride (mirapex) Review and Pramipexol Dihydrochloride (mirapex) Label ), CARBIDOPA + LEVODOPA (50 Mg, Qd) (View Carbidopa + Levodopa Review and Carbidopa + Levodopa Label ). Patient was hospitalized.

6679318-8 | Aortic Valve Incompetence, Cardiac Failure, Mitral Valve Incompetence
on Mar 25, 2010 Male patient from ITALY , 72 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Cabergoline (View Usage). Patient had the following side effects: aortic valve incompetence, cardiac failure, mitral valve incompetence. Cabergoline dosage: . Patient was hospitalized.

6678640-9 | Retroperitoneal Fibrosis
on Mar 31, 2010 Female patient from JAPAN , 45 years of age, was diagnosed with hypophysitis, hyperprolactinaemia, galactorrhoea and was treated with Cabergoline (View Usage). After Cabergoline was administered, patient had the following side effects: retroperitoneal fibrosis. Cabergoline dosage: .

6674401-5 | Dizziness, Feeling Abnormal, Oedema Peripheral, Visual Impairment
Patient was taking Cabergoline (View Usage). Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), feeling abnormal, oedema peripheral, visual impairment on Mar 29, 2010 from GERMANY Additional patient health information: Female patient , 70 years of age, weighting 151.0 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Cabergoline dosage: 2 Mg, 2x/day.

6668293-8 | Cerebrospinal Fluid Rhinorrhoea
Adverse event was reported on Mar 24, 2010 by a Male patient taking Cabergoline (View Usage) (Dosage: 0.25 Mg, Weekly) was diagnosed with prolactin-producing pituitary tumour and. Location: JAPAN , 40 years of age, Patient had the following side effects: cerebrospinal fluid rhinorrhoea.

6668291-4 | Cerebrospinal Fluid Rhinorrhoea, Meningitis Bacterial
on Mar 24, 2010 Male patient from JAPAN , 41 years of age, was diagnosed with pituitary tumour benign and was treated with Cabergoline (View Usage). After Cabergoline was administered, patient had the following side effects: cerebrospinal fluid rhinorrhoea, meningitis bacterial. Cabergoline dosage: .

6659923-5 | C-reactive Protein Increased, Lymphocyte Stimulation Test Positive, Oedema, Pleural Effusion
on Mar 11, 2010 Male patient from JAPAN , 80 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Cabergoline (View Usage). Patient experienced the following unwanted or unexpected effects: c-reactive protein increased, lymphocyte stimulation test positive, oedema, pleural effusion. Cabergoline dosage: 3 Mg Daily.

6656484-1 | Aggression, Hypersexuality, Libido Increased, Masked Facies, Pathological Gambling, Psychomotor Skills Impaired, Tremor
Patient was taking Cabergoline (View Usage). Patient had the following side effects: aggression, hypersexuality, libido increased, masked facies, pathological gambling, psychomotor skills impaired, tremor on Mar 17, 2010 from GERMANY Additional patient health information: Male patient , 35 years of age, weighting 172.0 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Cabergoline dosage: 4mg/day. During the same period patient was treated with TREMARIT (Unk) (View Tremarit Review and Tremarit Label ), CIALIS (10 Mg, Unk) (View Cialis Review and Cialis Label ).

Showing 1-50 of 516  Next Page  >


Share Your Experience, Join the Discussion:

Go to the top of the page

Cabergoline Questions, Answers, Feedback and Comments

Comments to date: 2. Page 1 of 1.

rajesh bhandari   ghaziabad

5:53am on Tuesday, October 20th, 2009

cabergoline is safe in pragancy if it is safe how it is safe

Dee   Location unknown

2:07pm on Saturday, January 10th, 2009

My doctor started me off with Bromocriptine but the side effects were so terrible, the blurred visio... read more »

To find out about documented side effects or safety concerns read either the drug label or the drug's package insert. You may also want to speak with your pharmacist or healthcare provider. All medicines have benefits and risks. The risks are the chances that something unwanted or unexpected could happen to you when you use them. You can protect yourself by searching summaries of recent safety alerts, adverse reports. Sometimes there are risks that only come to light after a medical product gets on the market and is used in a larger number of patients, for a longer period of time, and in patients whose health characteristics are different from those of the patients studied before approval.

Be aware of the following potential Cabergoline risks to be aware of: 1. Watch for any Serious adverse events, such as life-threatening situation, which can require an admission to hospital or longer-than-expected hospital stay, permanent disability, birth defect, miscarriage, stillbirth, or birth with serious disease requires medical care to prevent permanent damage
2. Any potential Cabergoline quality problem: suspected counterfeit product, potentially contaminated product indicated by suspicious odor or unusual color, inaccurate or unreadable product labeling
3. Potential Cabergoline use error: mixing up products with similar drug names or packaging, taking wrong dose of a drug because of confusing dosing instructions on label
4. When applicable, Problems with different manufacturer of same medicine: not getting same results from a generic drug as a brand name drug, or from another generic

Go to the top of the page
Go to the top of the page

Mobile version
How Did You Deal with Side Effects?

About Cabergoline : Risks and Benefits, News and Updates, Cabergoline video and TV resources

DOSTINEX - cabergoline tablet Pharmacia and Upjohn Company-----DOSTINEX ® cabergoline tablets. DESCRIPTION. DOSTINEX Tablets contain cabergoline, a dopamine ...

Post Cabergoline Side Effect Reporting Your Cabergoline side effect will help others recognize and deal with Cabergoline side effects. Recent Reports View Cabergoline ...

Cabergoline Side Effects - Complete Patient's Guide | User Reviews: Female patient, 65 years of age, weighting 149.9 | 9|Hypersexual|Extreme Fatigue|Backache|Pleural ...

During the same period patient was treated with CABERGOLINE ((0.5 Mg)) (View Cabergoline Review and Cabergoline Label ), LIPITOR (View Lipitor Review and Lipitor Label ), ...

Dostinex (25mg a week) Side Effect Report#7381 depression, anger, confusion, sleepy, mostly anger outbursts. About Cabergoline | Risks and Benefits

DOSTINEX - cabergoline tablet Pharmacia and Upjohn Company-----DOSTINEX ® cabergoline tablets. DESCRIPTION. DOSTINEX Tablets contain cabergoline, a dopamine ...

During the same period patient was treated with CABERGOLINE (2 Every 1 Weeks) (View Cabergoline Review and Cabergoline Label ), THYROID TAB (View Thyroid Tab Review and ...

I have prolactinoma, and I need to take cabergoline (Dostinex), and currently I am in China and, guess what, there is no Dostinex in the entire bloody country.

> Medical Devices

> Side Effects Wiki

Follow Us on Twitter

Cabergoline Reactions
Agitation
Aortic Valve Incompetence
Aortic Valve Sclerosis
Blood Creatine Phosphokinase Increased
Blood Prolactin Increased
Cardiac Failure
Cardiac Murmur
Cardiac Valve Disease
Cardiomegaly
Cerebrospinal Fluid Rhinorrhoea
Condition Aggravated
Cough
Delusion
Dyspnoea
Dyspnoea Exertional
FallWhat is Fall?
Fatigue
Hallucination
HeadacheWhat is Headache?
Interstitial Lung Disease
Mitral Valve Disease
Mitral Valve Incompetence
Mitral Valve Sclerosis
Myocardial Infarction
Oedema Peripheral
Pathological Gambling
Pleural Effusion
Pleural Fibrosis
Pulmonary HypertensionWhat is Pulmonary hypertension?
Tricuspid Valve Incompetence
Cabergoline Side Effects Notice - The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. PatientsVille.com does not provide medical advice, diagnosis or treatment. The information regarding Cabergoline adverse reports, reviews and polls contained on PatientsVille.com site has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of adverse drug reactions or for establishing or changing of patient treatments. Thank you for visiting Patientsville.com!